Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

The wolframin His611Arg polymorphism influences medication overuse headache.

Di Lorenzo C, Sances G, Di Lorenzo G, Rengo C, Ghiotto N, Guaschino E, Perrotta A, Santorelli FM, Grieco GS, Troisi A, Siracusano A, Pierelli F, Nappi G, Casali C.

Neurosci Lett. 2007 Sep 13;424(3):179-84. Epub 2007 Aug 6.

PMID:
17719176
2.

Molecular detection of novel WFS1 mutations in patients with Wolfram syndrome by a DHPLC-based assay.

Colosimo A, Guida V, Rigoli L, Di Bella C, De Luca A, Briuglia S, Stuppia L, Salpietro DC, Dallapiccola B.

Hum Mutat. 2003 Jun;21(6):622-9.

PMID:
12754709
3.

WFS1/wolframin mutations, Wolfram syndrome, and associated diseases.

Khanim F, Kirk J, Latif F, Barrett TG.

Hum Mutat. 2001 May;17(5):357-67. Review.

PMID:
11317350
4.

Drug consumption in medication overuse headache is influenced by brain-derived neurotrophic factor Val66Met polymorphism.

Di Lorenzo C, Di Lorenzo G, Sances G, Ghiotto N, Guaschino E, Grieco GS, Santorelli FM, Casali C, Troisi A, Siracusano A, Pierelli F.

J Headache Pain. 2009 Oct;10(5):349-55. doi: 10.1007/s10194-009-0136-0. Epub 2009 Jun 11.

5.

Family history for chronic headache and drug overuse as a risk factor for headache chronification.

Cevoli S, Sancisi E, Grimaldi D, Pierangeli G, Zanigni S, Nicodemo M, Cortelli P, Montagna P.

Headache. 2009 Mar;49(3):412-8. doi: 10.1111/j.1526-4610.2008.01257.x.

PMID:
19267785
6.

Association of haplotype combination of serotonin transporter gene polymorphisms with monthly headache days in MOH patients.

Terrazzino S, Tassorelli C, Sances G, Allena M, Viana M, Monaco F, Bellomo G, Nappi G, Canonico PL, Genazzani AA.

Eur J Neurol. 2012 Jan;19(1):69-75. doi: 10.1111/j.1468-1331.2011.03436.x. Epub 2011 May 18.

PMID:
21585624
7.

Obsessive-compulsive disorder and migraine with medication-overuse headache.

Cupini LM, De Murtas M, Costa C, Mancini M, Eusebi P, Sarchielli P, Calabresi P.

Headache. 2009 Jul;49(7):1005-13. doi: 10.1111/j.1526-4610.2009.01457.x. Epub 2009 Jun 1.

PMID:
19496831
8.

Behavioral dependence in patients with medication overuse headache: a cross-sectional study in consulting patients using the DSM-IV criteria.

Radat F, Creac'h C, Guegan-Massardier E, Mick G, Guy N, Fabre N, Giraud P, Nachit-Ouinekh F, Lantéri-Minet M.

Headache. 2008 Jul;48(7):1026-36. Epub 2007 Dec 11.

PMID:
18081820
9.

Association study of the effect of WFS1 polymorphisms on risk of type 2 diabetes in Japanese population.

Mita M, Miyake K, Zenibayashi M, Hirota Y, Teranishi T, Kouyama K, Sakaguchi K, Kasuga M.

Kobe J Med Sci. 2008 Oct 30;54(4):E192-9.

10.

Familial Wolfram syndrome due to compound heterozygosity for two novel WFS1 mutations.

Zenteno JC, Ruiz G, Pérez-Cano HJ, Camargo M.

Mol Vis. 2008 Jul 25;14:1353-7.

11.

WFS1 mutations in Spanish patients with diabetes mellitus and deafness.

Domènech E, Gómez-Zaera M, Nunes V.

Eur J Hum Genet. 2002 Jul;10(7):421-6.

12.

Wolframin mutations and hospitalization for psychiatric illness.

Swift M, Swift RG.

Mol Psychiatry. 2005 Aug;10(8):799-803.

PMID:
15852062
13.

Wolfram syndrome: structural and functional analyses of mutant and wild-type wolframin, the WFS1 gene product.

Hofmann S, Philbrook C, Gerbitz KD, Bauer MF.

Hum Mol Genet. 2003 Aug 15;12(16):2003-12.

PMID:
12913071
14.

Involvement of corticotrophin-releasing factor and orexin-A in chronic migraine and medication-overuse headache: findings from cerebrospinal fluid.

Sarchielli P, Rainero I, Coppola F, Rossi C, Mancini M, Pinessi L, Calabresi P.

Cephalalgia. 2008 Jul;28(7):714-22. doi: 10.1111/j.1468-2982.2008.01566.x. Epub 2008 May 13.

PMID:
18479471
15.

WFS1 mutations are frequent monogenic causes of juvenile-onset diabetes mellitus in Lebanon.

Zalloua PA, Azar ST, Delépine M, Makhoul NJ, Blanc H, Sanyoura M, Lavergne A, Stankov K, Lemainque A, Baz P, Julier C.

Hum Mol Genet. 2008 Dec 15;17(24):4012-21. doi: 10.1093/hmg/ddn304. Epub 2008 Sep 20.

PMID:
18806274
16.

Wolfram syndrome-associated mutations lead to instability and proteasomal degradation of wolframin.

Hofmann S, Bauer MF.

FEBS Lett. 2006 Jul 10;580(16):4000-4. Epub 2006 Jun 22.

17.
18.

hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease.

Yang SF, Xu YJ, Xie JG, Zhang ZX.

Chin Med J (Engl). 2009 Apr 20;122(8):960-6.

PMID:
19493423
19.

Medication overuse headache: clinical features predicting treatment outcome at 1-year follow-up.

Zidverc-Trajkovic J, Pekmezovic T, Jovanovic Z, Pavlovic A, Mijajlovic M, Radojicic A, Sternic N.

Cephalalgia. 2007 Nov;27(11):1219-25. Epub 2007 Sep 21.

PMID:
17888081
20.

Past, present, and future prospects of medication-overuse headache classification.

Ferrari A, Coccia C, Sternieri E.

Headache. 2008 Jul;48(7):1096-102. doi: 10.1111/j.1526-4610.2008.00919.x. Review.

PMID:
18687082

Supplemental Content

Support Center